HH

Haiying He

CC Chia Tai Tianqing Pharmaceutical Group Co.: 4 patents #1 of 78Top 2%
SC Shanghai Haiyan Pharmaceutical Technology Co.: 2 patents #4 of 33Top 15%
YC Yangtze River Pharmaceutical Group Co.: 2 patents #4 of 39Top 15%
Johnson & Johnson: 2 patents #255 of 1,204Top 25%
MD Medshine Discovery: 1 patents #8 of 39Top 25%
📍 Lo Wu, CN: #32 of 1,037 inventorsTop 4%
Overall (2021): #6,907 of 548,734Top 2%
11
Patents 2021

Issued Patents 2021

Showing 1–11 of 11 patents

Patent #TitleCo-InventorsDate
11149055 Crystal form of lanosterol prodrug compound and application thereof Yizhi Liu, Yandong WANG, Xiaolin Li, Zhi Luo, Jian Li +1 more 2021-10-19
11091450 Crystal of a caspase inhibitor Songliang Wu, Jianfeng Mou 2021-08-17
11059854 Method for preparing steroid derivative FXR agonist Xiaolin Li, Hualing Xiao, Peng Li, Fei Hao 2021-07-13
11059853 Crystalline or amorphous form of steroid derivative FXR agonist, preparation method therefor and use thereof Xiaolin Li, Hualing Xiao, Peng Li, Weidong Li 2021-07-13
11053260 Tri-cycle compound and applications thereof Jing Wang, Zhigan Jiang, Yaxun YANG, Peng Shao, Chen ZHANG +2 more 2021-07-06
11021444 Antiviral compounds Guangyi Wang, Leonid Beigelman, Anh Truong, Carmela Napolitano, Daniele Andreotti +1 more 2021-06-01
11014935 Compounds for the treatment of paramyxovirus viral infections Guangyi Wang, Leonid Beigelman, Anh Truong, Carmela Napolitano, Daniele Andreotti 2021-05-25
11001563 SSAO inhibitor Zhi Luo, Xiaolin Li, Yaxun YANG, Lele Yang, Peng Li +2 more 2021-05-11
10981860 Caspase inhibitor and pharmaceutical composition, use and therapeutic method thereof Songliang Wu, Zhi Luo, Jianfeng Mou, Fengying Guo, Chuan Wang +3 more 2021-04-20
10912775 Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Songliang Wu, Zhi Luo, Yuan Chen, Yuhe Wang, Dakun Qin +3 more 2021-02-09
10898486 Crystal form of orexin receptor antagonist compound, and preparation method and application thereof Songliang Wu, Zhi Luo, Yuan Chen, Yuhe Wang, Dakun Qin +3 more 2021-01-26